Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Income from Continuing Operations came in at 121362000.0 in Q2 2026, up 34.46% YoY from 90260000.0 in Q2 2025, and down 2.02% on a QoQ basis from 123870000.0 in Q1 2026.
Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Income from Continuing Operations data on file, last reported at 121362000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 34.46% year-over-year to 121362000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 491500000.0 (up 17.5% YoY) and the FY2025 annual result came in at 451123000.0, up 11.56% from the prior year.
- Income from Continuing Operations eased to 121362000.0 in Q2 2026, from 123870000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 135133000.0 in Q4 2025 to a low of 49360000.0 in Q2 2022.
- A 5-year average of 90495500.0 and a median of 89305500.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 49.45% — and 2025, when it rose 2.16%.
- Tracing MEDP's Income from Continuing Operations over 5 years: stood at 68670000.0 in 2022, then climbed by 14.02% to 78298000.0 in 2023, then surged by 49.45% to 117018000.0 in 2024, then increased by 15.48% to 135133000.0 in 2025, then fell by 10.19% to 121362000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 121362000.0 (Q2 2026), 123870000.0 (Q1 2026), and 135133000.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 121.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 121.36 Mn |
| Mar 31, 2026 | 123.87 Mn |
| Dec 31, 2025 | 135.13 Mn |
| Sep 30, 2025 | 111.14 Mn |
| Jun 30, 2025 | 90.26 Mn |
| Mar 31, 2025 | 114.60 Mn |
| Dec 31, 2024 | 117.02 Mn |
| Sep 30, 2024 | 96.43 Mn |
| Jun 30, 2024 | 88.35 Mn |
| Mar 31, 2024 | 102.59 Mn |
| Dec 31, 2023 | 78.30 Mn |
| Sep 30, 2023 | 70.55 Mn |
| Jun 30, 2023 | 61.07 Mn |
| Mar 31, 2023 | 72.89 Mn |
| Dec 31, 2022 | 68.67 Mn |
| Sep 30, 2022 | 66.03 Mn |
| Jun 30, 2022 | 49.36 Mn |
| Mar 31, 2022 | 61.31 Mn |
| Dec 31, 2021 | 50.03 Mn |
| Sep 30, 2021 | 48.57 Mn |